We are live on ! Find out more
CLLS

Cellectis
CLLS

Fund managers haven’t disclosed any holdings of CLLS yet.

CLLS Hedge Fund Activity: Q1 2026 in Review

32 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q1 2026, worth a combined $32.5M — down 36% from $51.1M a quarter earlier.

Fund positioning in CLLS was balanced in Q1 2026: 4 funds opened new positions, 4 closed out, 3 added to existing stakes and 14 trimmed.

The largest buyer was XTX Topco, opening a new position worth an estimated $62.4K. The largest seller was Marshall Wace, cutting an estimated $527K.

  • 32 institutional investors held Cellectis (CLLS) as of Q1 2026, down from 34 in Q4 2025.
  • Funds reported $32.5M of Cellectis stock for Q1 2026, down 36% quarter-over-quarter.
  • 4 funds opened new Cellectis positions in Q1 2026 and 4 closed out, a net change of 0 holders.
  • The largest Cellectis buyer in Q1 2026 was XTX Topco, an estimated $62.4K added.
  • The largest Cellectis seller in Q1 2026 was Marshall Wace, an estimated $527K sold.

Based on aggregated 13F filings for Q1 2026.